Anti-VEGF agents are considered to have equivalent efficacy and safety profiles in AMD treatment.
Learn more about the use of antiangiogenic agents for management of wet AMD.
Editor's Recommendations
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: F. Ryan Prall. Fast Five Quiz: Exudative (Wet) Age-Related Macular Degeneration (AMD) - Medscape - Oct 15, 2020.
Comments